Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets, Volume 8 - Number 8
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
, 8(8): 647 - 665Paolo Baldo, Sara Cecco, Elisa Giacomin, Renzo Lazzarini, Barbara Ros and Stefano Marastoni
DOI: 10.2174/156800908786733513
Anticancer Immunotherapy in Combination with Proapoptotic Therapy
, 8(8): 666 - 675Oystein Bruserud, Elisabeth Ersvaer, Astrid Olsnes and Bjorn Tore Gjertsen
DOI: 10.2174/156800908786733496
Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma
, 8(8): 676 - 682Daniel Y.C. Heng and Ronald M. Bukowski
DOI: 10.2174/156800908786733450
PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
, 8(8): 683 - 690Crispin R. Dass, Eugene T.H. Ek and Peter F.M. Choong
DOI: 10.2174/156800908786733487
Melatonin as a Selective Estrogen Enzyme Modulator
, 8(8): 691 - 702S. Cos, A. Gonzalez, C. Martinez-Campa, M. D. Mediavilla, C. Alonso-Gonzalez and E. J. Sanchez-Barcelo
DOI: 10.2174/156800908786733469
Budesonide and Phenethyl Isothiocyanate Attenuate DNA Damage in Bronchoalveolar Lavage Cells of Mice Exposed to Environmental Cigarette Smoke
, 8(8): 703 - 708Rosanna T. Micale, Francesco D'Agostini, Vernon E. Steele, Sebastiano La Maestra and Silvio De Flora
DOI: 10.2174/156800908786733423
Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells
, 8(8): 709 - 719Monica Banez-Coronel, Ana Ramirez de Molina, Agustin Rodriguez-Gonzalez, Jacinto Sarmentero, Mª Angeles Ramos, Miguel Angel Garcia-Cabezas, Lourdes Garcia-Oroz and Juan Carlos Lacal
DOI: 10.2174/156800908786733432
ADAM Proteins- Therapeutic Potential in Cancer
, 8(8): 720 - 732Xinjie Lu, Dong Lu, Mike Scully and Vijay Kakkar
DOI: 10.2174/156800908786733478
The PIK3CA Gene as a Mutated Target for Cancer Therapy
, 8(8): 733 - 740John P. Gustin, David P. Cosgrove and Ben Ho Park
DOI: 10.2174/156800908786733504
Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)
, 8(8): 741 - 752Ankur Kumar Upadhyay, Amrendra Kumar Ajay, Sandeep Singh and Manoj Kumar Bhat
DOI: 10.2174/156800908786733405
Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype
, 8(8): 753 - 764C. Siemes, L. E. Visser, J. W.W. Coebergh, A. Hofman, A. G. Uitterlinden and B.H. Ch. Stricker
DOI: 10.2174/156800908786733414
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net